Dare Bioscience, Inc. - חוב לטווח קצר של החברה DARE

The credit rating of Dare Bioscience, Inc. (DARE) is based on revenues from the sale of women's health products and royalties. The level of short-term debt load demonstrates price stability, while 0.00 reflects the latest metric level. Financial stability is bolstered by alliances with pharma behemoths to bring products to market and a stable staff of specialized scientists with clinical experience.

For women's health innovator Dare Bioscience, Inc. (DARE), the history of short-term credits and loans reflects the ability to fund the development of unique drug delivery systems without critical pressure on liquidity. This indicator aggregates all obligations with a maturity of up to one year, allowing investors to assess default risk and the efficiency of working capital management within the context of capital-intensive medical research.